Sca1(+) mesenchymal stromal cells inhibit graft-versus-host disease in mice after bone marrow transplantation

International Immunopharmacology
Fan WenXingbin Hu

Abstract

Mesenchymal stromal cells (MSCs) have therapeutic potential for the prevention and treatment of graft-versus-host disease (GVHD). However, MSCs comprise several subpopulations, which have not been individually assessed for their role in GVHD suppression. In this study, we assessed the immunosuppressive effect of bone-related Sca1(+) MSCs on acute GVHD in a MHC-mismatched mouse model of allogeneic hematopoietic stem cell transplantation (HCT). Our results showed that Sca1(+) MSCs decreased the severity of acute GVHD (aGVHD) and prolonged the survival period of allogeneic HCT recipients. This effect was exerted through lowered T lymphocyte infiltration in target organs and by inhibition of CD80/86 expression on host dendritic cells. Furthermore, the expression of cytotoxic T-lymphocyte antigen-4 (CTLA-4), a negative regulator of T cells, was elevated in the recipient splenocytes. In conclusion, bone-related Sca1(+) MSCs subpopulation suppressed GVHD and could be a novel treatment for acute GVHD.

References

Mar 4, 1993·The New England Journal of Medicine·N A KernanJ McCullough
Apr 2, 1999·Science·M F PittengerD R Marshak
Jan 13, 2004·Blood·Angela Panoskaltsis-MortariBruce R Blazar
Oct 21, 2004·Blood·Sudeepta Aggarwal, Mark F Pittenger
Mar 22, 2005·Experimental Cell Research·Ida RasmussonKatarina Le Blanc
Nov 9, 2007·AJNR. American Journal of Neuroradiology·M Judith Donovan Post
May 13, 2008·Lancet·Katarina Le BlancUNKNOWN Developmental Committee of the European Group for Blood and Marrow Transplantation
Dec 8, 2009·Stem Cells·Husein K Salem, Chris Thiemermann
Jul 3, 2010·Stem Cells·Jakub TolarBruce R Blazar
Jan 15, 2011·Cytotherapy·Partow Kebriaei, Simon Robinson
May 3, 2011·Seminars in Immunopathology·Ian B Copland, Jacques Galipeau
May 12, 2011·Disease Models & Mechanisms·Mark A Schroeder, John F DiPersio
May 9, 2012·Frontiers in Immunology·Martina M McGrath, Nader Najafian
May 12, 2012·Nature Reviews. Immunology·Bruce R BlazarMehrdad Abedi
Dec 18, 2013·European Journal of Immunology·Aleksandra KowalczykLi Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.